- Issuer ticker
-
LIMN
- Reported as of
-
24 Jun 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
3
- Accepted by SEC
-
06 Jul 2026, 16:57:35 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Joo Sung Park
Key filing fact
Ewon Comfortech Co., Ltd. filed Form 3 for Liminatus Pharma, Inc. (LIMN) on 06 Jul 2026.
Key facts
- This page summarizes Ewon Comfortech Co., Ltd.'s Form 3 filing for Liminatus Pharma, Inc. (LIMN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Jul 2026, 16:57.
Change
- Previous filing in this sequence was filed on 13 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0001973072
Primary reporting owner
Ewon Comfortech Co., Ltd.
- Relationship
-
10%+ Owner
- Address
- 8 CHEOMDAN 1-RO JEONGEUP, JEONBUK, KOREA, REPUBLIC OF
- Signature
- /s/ Joo Sung Park
- Signature date
- 06 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIMN
holding
Common Stock, par value $0.0001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 5,500,000
- Date
- 24 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote